[ERCP in the diagnosis of bilio-pancreatic pathology. Comparison with echography and CT].

PubWeight™: 0.76‹?›

🔗 View Article (PMID 2667044)

Published in Radiol Med on June 01, 1989

Authors

T Scarabino1, S Petronelli, D Palladino, S Balzano, T Federici, L Accadia, V Annese, N Caruso

Author Affiliations

1: Dipartimento di Diagnostica per Immagini, Ospedale Regionale Generale, Casa Sollievo della Sofferenza, San Giovanni Rotondo, FG.

Articles by these authors

Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study. Dig Liver Dis (2001) 2.30

Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations. Aliment Pharmacol Ther (2012) 2.28

Gene-centric association mapping of chromosome 3p implicates MST1 in IBD pathogenesis. Mucosal Immunol (2008) 2.28

Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86

Proton-pump inhibitors and outcome of endoscopic hemostasis in bleeding peptic ulcers: a series of meta-analyses. Am J Gastroenterol (2005) 1.85

Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis. Gut (2009) 1.65

Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol (2005) 1.64

Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. Gastroenterology (1992) 1.62

Detection of abnormal lesions recorded by capsule endoscopy. A prospective study comparing endoscopist's and nurse's accuracy. Dig Liver Dis (2006) 1.61

Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Dig Liver Dis (2005) 1.57

Appendectomy is an independent protective factor for ulcerative colitis: results of a multicentre case control study. The Italian Group for the Study of the Colon and Rectum (GISC) Ital J Gastroenterol Hepatol (1997) 1.53

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Dig Liver Dis (2007) 1.43

Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group. Ital J Gastroenterol Hepatol (1999) 1.42

The influence of parity on multinodular goiter prevalence in areas with moderate iodine deficiency. J Endocrinol Invest (2002) 1.40

Microscopic colitis progressed to collagenous colitis: a morphometric study. Ital J Gastroenterol (1996) 1.39

Helicobacter pylori infection and growth delay in older children. Arch Dis Child (1997) 1.39

Congenital absence of the internal carotid artery. Cardiovasc Intervent Radiol (1999) 1.33

Increased intestinal permeability and NOD2 variants in familial and sporadic Crohn's disease. Aliment Pharmacol Ther (2006) 1.29

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study. Radiology (2000) 1.20

Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther (2007) 1.18

Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies. Am J Gastroenterol (2001) 1.13

Patterns of symptoms in functional dyspepsia: role of Helicobacter pylori infection and delayed gastric emptying. Am J Gastroenterol (1998) 1.12

Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis. Aliment Pharmacol Ther (1998) 1.08

Congenital intrahepatic portosystemic shunt. Cardiovasc Intervent Radiol (1999) 1.06

Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther (2002) 1.04

Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Gastroenterology (1999) 1.01

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis (2011) 1.00

Botulinum toxin injection versus laparoscopic myotomy for the treatment of esophageal achalasia: economic analysis of a randomized trial. Surg Endosc (2004) 1.00

Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther (2006) 0.99

Screening of nineteen unrelated families with generalized resistance to thyroid hormone for known point mutations in the thyroid hormone receptor beta gene and the detection of a new mutation. J Clin Invest (1991) 0.98

The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom Study of 209 pregnant women. Aliment Pharmacol Ther (2013) 0.97

Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol (1999) 0.97

Polymorphism of the IRGM gene might predispose to fistulizing behavior in Crohn's disease. Am J Gastroenterol (2009) 0.95

Fatal ulcerative panenteritis following colectomy in a patient with ulcerative colitis. Dig Dis Sci (1999) 0.94

Perendoscopic injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilation. Gastrointest Endosc (1996) 0.94

Sustained virological responses following standard anti-viral therapy in decompensated HCV-infected cirrhotic patients. Aliment Pharmacol Ther (2009) 0.94

Acromegaloid facial appearance (AFA) syndrome: report of a second family. J Med Genet (1992) 0.94

A new method of biofeedback in the management of low vision. Eye (Lond) (2002) 0.91

MAST3: a novel IBD risk factor that modulates TLR4 signaling. Genes Immun (2008) 0.90

Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy. Aliment Pharmacol Ther (2007) 0.90

Treatment with botulinum toxin of octo-nonagerians with oesophageal achalasia: a two-year follow-up study. Aliment Pharmacol Ther (2006) 0.90

Different expression of synemin isoforms in glia and neurons during nervous system development. Glia (2006) 0.89

The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Aliment Pharmacol Ther (2007) 0.89

Idiopathic achalasia is not allelic to alacrima achalasia adrenal insufficiency syndrome at the ALADIN locus. Dig Liver Dis (2005) 0.89

Review article: pharmacological options in achalasia. Aliment Pharmacol Ther (1999) 0.89

HLA antigens and pANCA define ulcerative colitis as a genetically heterogeneous disorder. Ital J Gastroenterol Hepatol (1998) 0.88

Gallbladder function and gastric liquid emptying in achalasia. Dig Dis Sci (1991) 0.88

Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial. Aliment Pharmacol Ther (2003) 0.87

General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum (2007) 0.86

Antroduodenojejunal manometry in the diagnosis of chronic idiopathic intestinal pseudoobstruction in children. J Pediatr Gastroenterol Nutr (1994) 0.86

Nifedipine and verapamil inhibit the sigmoid colon myoelectric response to eating in healthy volunteers. Dis Colon Rectum (1998) 0.86

Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole. Dig Liver Dis (2005) 0.85

Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study. Dig Liver Dis (2008) 0.85

Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts. J Med Genet (2007) 0.85

Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto. Aliment Pharmacol Ther (1999) 0.85

Multidrug resistance 1 gene polymorphisms are not associated with inflammatory bowel disease and response to therapy in Italian patients. Aliment Pharmacol Ther (2005) 0.84

Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature. Dis Colon Rectum (2000) 0.83

HLA and enteric antineuronal antibodies in patients with achalasia. Neurogastroenterol Motil (2006) 0.83

Bursts of non-deglutitive simultaneous contractions may be a normal oesophageal motility pattern. Gut (1993) 0.83

HLA-DRB1 alleles may influence disease phenotype in patients with inflammatory bowel disease: a critical reappraisal with review of the literature. Dis Colon Rectum (2005) 0.83

The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. Gastroenterology (2004) 0.82

Erythrocytes as a controlled drug delivery system: clinical evidences. J Control Release (2006) 0.82

IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease. Cell Death Dis (2012) 0.82

Relapsing polychondritis with severe aortic insufficiency. Clin Rheumatol (1985) 0.82

The importance of endoscopic ultrasonography in the management of low-grade gastric mucosa-associated lymphoid tissue lymphoma. Aliment Pharmacol Ther (2002) 0.81

A normal gastrointestinal motility excludes chronic intestinal pseudoobstruction in children. Dig Dis Sci (2000) 0.81

Is the irritable bowel really irritable? Ital J Gastroenterol (1991) 0.81

Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders. J Clin Endocrinol Metab (1987) 0.81

Therapy of Graves' disease with sodium ipodate is associated with a high recurrence rate of hyperthyroidism. J Endocrinol Invest (1991) 0.80

Twenty-four hour ambulatory antroduodenal manometry in normal subjects (co-operative study). Neurogastroenterol Motil (2000) 0.80

Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study. World J Gastroenterol (2005) 0.80

Role of CARD15, DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases. World J Gastroenterol (2007) 0.79

Regularized least squares classifiers may predict Crohn's disease from profiles of single nucleotide polymorphisms. Ann Hum Genet (2007) 0.79

Gastric emptying of solids is delayed in celiac disease and normalizes after gluten withdrawal. Acta Paediatr (2000) 0.79

Splenic abscess secondary to penetrating gastric ulcer. Minerva Gastroenterol Dietol (1998) 0.79

Association of ankylosing spondylitis with hairy cell leukemia: a previously once reported case. Z Rheumatol (1985) 0.79

13C-octanoic acid breath test for measuring gastric emptying of solids. Eur Rev Med Pharmacol Sci (2006) 0.79

Linkage analysis identifies gene carriers among members of families with hereditary nonpolyposis colorectal cancer. Gastroenterology (1996) 0.79

The aminopyrine breath test. Ital J Gastroenterol (1994) 0.78

Sequential treatment with lamivudine and alpha-interferon in anti-HBe-positive chronic hepatitis B patients: a pilot study. Dig Liver Dis (2007) 0.78

[Kommerell diverticulum. Current aspects of the imaging diagnosis]. Radiol Med (1989) 0.78

Multiple intrahepatic vascular shunts causing hyperammoniaemic encephalopathy in a patient without liver cirrhosis. Dig Liver Dis (2005) 0.78

Review article: endoscopic antireflux procedures - an unfulfilled promise? Aliment Pharmacol Ther (2007) 0.78

Gall stones in Crohn's disease: another hypothesis. Gut (1994) 0.78

Parity as a thyroid size-determining factor in areas with moderate iodine deficiency. J Clin Endocrinol Metab (2000) 0.78

Synemin isoforms in astroglial and neuronal cells from human central nervous system. Neurochem Res (2009) 0.78

Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy? Aliment Pharmacol Ther (2001) 0.78

Botulinum toxin in long-term therapy for achalasia. Ann Intern Med (1998) 0.78

Long-term treatment of duodenal ulcer with pirenzepine; gastric pH values and incidence of relapses: an open pilot study. Int J Tissue React (1983) 0.77

Long-term follow-up of achalasic patients treated with botulinum toxin. Dis Esophagus (2000) 0.77

Dose-related stimulatory effect of clarithromycin on interdigestive gastroduodenal motility. Digestion (2000) 0.77